Cargando…
The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials
BACKGROUND: Inflammation is critical to the pathogenesis and progression of cancer, with a high neutrophil–lymphocyte ratio (NLR) associated with poor prognosis. The utility of studying NLR in early clinical trials is unknown. METHODS: This retrospective study evaluated 1300 patients treated in phas...
Autores principales: | Kumar, R, Geuna, E, Michalarea, V, Guardascione, M, Naumann, U, Lorente, D, Kaye, S B, de Bono, J S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385959/ https://www.ncbi.nlm.nih.gov/pubmed/25719834 http://dx.doi.org/10.1038/bjc.2015.67 |
Ejemplares similares
-
Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function?
por: Tonyali, Senol, et al.
Publicado: (2018) -
The neutrophil-to-lymphocyte ratio may indicate when to start hemodialysis
por: Lee, Tae Won, et al.
Publicado: (2022) -
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
por: Kang, M H, et al.
Publicado: (2014) -
Predictive value of neutrophil/lymphocyte ratio in renal prognosis of patients with granulomatosis with polyangiitis
por: Küçük, Hamit, et al.
Publicado: (2016) -
The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)